Ticagrelor
antiplatelet agent
Nothing to addWhat this medicine is for
Ticagrelor is a medicine in the “antiplatelet agent” category. Antiplatelet agents prevent platelets from clumping together, which reduces the risk of a clot.
For Ticagrelor, in practice: Prevents platelets from forming clots. It is most often a long-term treatment, taken at set times over long periods; its benefit is judged over time, not by how you feel on a given day.
Under which brands it is found
In France, about 11 reimbursable presentations containing Ticagrelor are recorded. It comes under various trade names and in generic form.
- Brilique
- Ticagrelor Arrow
- Ticagrelor Biogaran
- Ticagrelor Eg
- Ticagrelor Evolugen
- Ticagrelor Krka
- Ticagrelor Sandoz
- Ticagrelor Teva
- and other presentations
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
We put forward no supplement for Ticagrelor: that would be forcing a need that does not exist. The great majority of medicines call for no particular supplementation, and acknowledging this is part of the way we work. We design a supplement only where the data support it, across five specific classes.
Talk about it in the community
A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.
Related molecules
To explore in the « Heart and rhythm » family and its neighbours.
See the whole « Heart and rhythm » family · Back to the atlas